The AngelMed Guardian® System in the Detection of Coronary Artery Occlusion: Current Perspectives
| Autor: | Sudarshana Datta, Gerald Chi, Syed Hassan A. Kazmi, Megan Yee, Sabawoon Mirwais, Akshun Kalia, C. Michael Gibson, Tarek Nafee, Fahimehalsadat Shojaei, Sadaf Sharfaei |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Acute coronary syndrome medicine.diagnostic_test Interventional cardiology business.industry medicine.medical_treatment Biomedical Engineering Medicine (miscellaneous) Percutaneous coronary intervention 030209 endocrinology & metabolism medicine.disease Chest pain 03 medical and health sciences 0302 clinical medicine Coronary occlusion Internal medicine Door-to-balloon medicine Cardiology Myocardial infarction medicine.symptom business Electrocardiography 030217 neurology & neurosurgery |
| Zdroj: | Medical Devices: Evidence and Research. 13:1-12 |
| ISSN: | 1179-1470 |
| DOI: | 10.2147/mder.s219865 |
| Popis: | Total ischemic time, which specifies the time from the onset of chest pain to initiation of reperfusion during percutaneous coronary intervention, consists of two intervals: symptom to door time and door to balloon time. A door to balloon time of 90 mins or less has become a quality-of-care metric in the management of ST elevation myocardial infarction (STEMI). While national efforts made by the American College of Cardiology (ACC) and American Heart Association (AHA) have curtailed in-hospital door to balloon time over the years, a reduction in pre-hospital symptoms to door time presents a challenge in modern interventional Cardiology. Early and complete revascularization has been associated with improved clinical outcomes in MI and strategies that may help reduce symptom to door time, and thus the total ischemic time, are crucial. Rapidly evolving ST-segment changes commonly develop prior to ischemia-related symptom onset, and are detectable even in patients with clinically unrecognized silent MIs. Therefore, a highly intelligent ischemia detection system that alerts patients of ST segment deviation may allow for rapid identification of acute coronary occlusion. The AngelMed Guardian® System is a cardiac activity monitoring and alerting system designed for rapid identification of intracardiac ST-segment changes among patients at a high risk for recurrent ACS events. This article reviews the clinical studies evaluating the design, safety and efficacy of the AngelMed Guardian System and discusses the clinical implications of the device. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|